213.85
price down icon0.29%   -0.62
after-market 시간 외 거래: 213.85
loading
전일 마감가:
$214.47
열려 있는:
$214.47
하루 거래량:
4.93M
Relative Volume:
0.91
시가총액:
$377.52B
수익:
$56.33B
순이익/손실:
$4.28B
주가수익비율:
89.10
EPS:
2.4
순현금흐름:
$17.83B
1주 성능:
+0.12%
1개월 성능:
+8.97%
6개월 성능:
+10.84%
1년 성능:
+19.81%
1일 변동 폭
Value
$212.27
$215.18
1주일 범위
Value
$208.28
$215.50
52주 변동 폭
Value
$153.58
$218.66

애브비 Stock (ABBV) Company Profile

Name
명칭
Abbvie Inc
Name
전화
(847) 932-7900
Name
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Name
직원
50,000
Name
트위터
@abbvie
Name
다음 수익 날짜
2025-01-31
Name
최신 SEC 제출 서류
Name
ABBV's Discussions on Twitter

ABBV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
ABBV
Abbvie Inc
213.85 377.52B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
LLY
Lilly Eli Co
822.51 738.75B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
80.98 359.47B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
JNJ
Johnson Johnson
164.25 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
MRK
Merck Co Inc
94.72 251.88B 64.17B 17.12B 18.10B 6.73

애브비 Stock (ABBV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-10 재개 BofA Securities Neutral
2024-12-05 다운그레이드 Daiwa Securities Outperform → Neutral
2024-11-22 업그레이드 Leerink Partners Market Perform → Outperform
2024-11-15 개시 Wolfe Research Outperform
2024-11-04 업그레이드 Argus Hold → Buy
2024-10-17 개시 Bernstein Mkt Perform
2024-06-05 업그레이드 HSBC Securities Hold → Buy
2024-05-17 개시 Cantor Fitzgerald Overweight
2024-01-29 업그레이드 William Blair Mkt Perform → Outperform
2023-12-18 다운그레이드 HSBC Securities Buy → Hold
2023-12-11 업그레이드 Goldman Neutral → Buy
2023-11-09 개시 Deutsche Bank Hold
2023-10-30 업그레이드 Barclays Equal Weight → Overweight
2023-10-20 재개 UBS Neutral
2023-09-29 개시 Raymond James Outperform
2023-07-25 개시 William Blair Mkt Perform
2023-07-14 개시 HSBC Securities Buy
2023-04-05 다운그레이드 Argus Buy → Hold
2023-03-01 개시 Guggenheim Buy
2023-02-22 다운그레이드 Wolfe Research Outperform → Peer Perform
2023-02-10 업그레이드 SVB Securities Underperform → Market Perform
2022-11-18 개시 Credit Suisse Outperform
2022-11-08 다운그레이드 Societe Generale Buy → Hold
2022-08-01 다운그레이드 Atlantic Equities Overweight → Neutral
2022-05-23 개시 SVB Leerink Underperform
2022-05-06 다운그레이드 Daiwa Securities Outperform → Neutral
2022-04-06 재개 Morgan Stanley Overweight
2022-02-28 다운그레이드 UBS Buy → Neutral
2022-02-03 재확인 BMO Capital Markets Outperform
2022-02-03 재확인 Barclays Equal Weight
2022-02-03 재확인 BofA Securities Neutral
2022-02-03 재확인 Goldman Neutral
2022-01-13 개시 Redburn Buy
2022-01-12 재확인 BMO Capital Markets Outperform
2021-12-09 재개 Wells Fargo Overweight
2021-11-23 업그레이드 Societe Generale Hold → Buy
2021-07-27 재개 Truist Buy
2021-04-07 재개 RBC Capital Mkts Outperform
2020-11-10 재개 Bernstein Outperform
2020-09-29 개시 Berenberg Hold
2020-06-23 업그레이드 Atlantic Equities Neutral → Overweight
2020-06-09 업그레이드 Wolfe Research Peer Perform → Outperform
2020-06-02 업그레이드 Argus Hold → Buy
2020-05-18 재개 BofA/Merrill Neutral
2020-05-12 업그레이드 JP Morgan Neutral → Overweight
2020-05-11 재개 Morgan Stanley Overweight
2020-04-20 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2020-03-23 다운그레이드 Societe Generale Buy → Hold
2020-02-27 개시 Barclays Equal Weight
2020-02-06 개시 Mizuho Buy
2020-01-07 개시 RBC Capital Mkts Sector Perform
2019-12-26 재확인 Cowen Outperform
2019-09-26 업그레이드 Citigroup Neutral → Buy
2019-08-20 업그레이드 Piper Jaffray Neutral → Overweight
2019-06-27 업그레이드 Wolfe Research Underperform → Peer Perform
2019-06-26 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-05-28 개시 Goldman Neutral
2019-04-29 업그레이드 BMO Capital Markets Underperform → Market Perform
모두보기

애브비 주식(ABBV)의 최신 뉴스

pulisher
05:12 AM

AbbVie CFO Scott Reents sells $3.75 million in stock - Investing.com

05:12 AM
pulisher
03:40 AM

Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical - openPR

03:40 AM
pulisher
09:20 AM

AbbVie upgraded to Buy at Erste Group on Friday - Yahoo Finance

09:20 AM
pulisher
Mar 17, 2025

AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

AbbVie’s Elahere demonstrates extended survival in Phase 3 MIRASOL trial - World Pharmaceutical Frontiers

Mar 17, 2025
pulisher
Mar 17, 2025

Erste Group lifts AbbVie stock rating to Buy on growth forecast - Investing.com UK

Mar 17, 2025
pulisher
Mar 17, 2025

AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

AbbVie builds the case for ovarian cancer drug Elahere - pharmaphorum

Mar 16, 2025
pulisher
Mar 16, 2025

AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer - Yahoo Finance

Mar 16, 2025
pulisher
Mar 15, 2025

AbbVie : Phase 3 Data Shows ELAHERE Cuts Death Risk By 32% In FRa-Positive PROC - Nasdaq

Mar 15, 2025
pulisher
Mar 14, 2025

Top Analyst Reports for AbbVie, Lockheed Martin & Dell - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk (NYSE:ABBV) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 13, 2025

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Verrica Pharmaceuticals, - EIN News

Mar 13, 2025
pulisher
Mar 12, 2025

DNA Repair Drugs Market May See a Big Move | Major Giants- AbbVie, AstraZeneca, AstraZeneca - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

AbbVie’s SWOT analysis: biopharmaceutical giant’s stock faces challenges and opportunities - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Calls of the Day: United Airlines, Delta, IBM, Abbvie, Uber - CNBC

Mar 12, 2025
pulisher
Mar 12, 2025

ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN

Mar 12, 2025
pulisher
Mar 12, 2025

Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 12, 2025

AbbVie: Hold Rating Maintained Amid Strong Skyrizi Sales and Valuation Concerns - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Berenberg Adjusts Price Target on AbbVie to $195 From $165, Maintains Hold Rating -March 12, 2025 at 06:30 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Abbvie, Dick's Sporting, Oracle - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

(03/12/25) ABBV: A Higher-Yielding Healthcare Play That Continues to Shine - Moneyshow.com

Mar 12, 2025
pulisher
Mar 11, 2025

11 Best Pharma Stocks to Buy According to Hedge Funds - Insider Monkey

Mar 11, 2025
pulisher
Mar 11, 2025

Why AbbVie (ABBV) Dipped More Than Broader Market Today - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

10 Health Care Stocks Whale Activity In Today's Session - Benzinga

Mar 11, 2025
pulisher
Mar 11, 2025

AbbVie at Leerink’s Global Healthcare Conference: Strategic Growth Path - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

AbbVie at Leerink’s Global Healthcare Conference: Strategic Growth Path By Investing.com - Investing.com UK

Mar 11, 2025
pulisher
Mar 11, 2025

Xilio advances cancer treatments, secures AbbVie collaboration - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Xilio Lands Massive $2.1B AbbVie Partnership as Phase 2 Cancer Drug Shows Promise - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In - Insider Monkey

Mar 11, 2025
pulisher
Mar 11, 2025

Rep. Jefferson Shreve Purchases Shares of AbbVie Inc. (NYSE:ABBV) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Abbvie Says CEO Robert Michael's 2024 Total Compensation Was $18.5 Million -March 10, 2025 at 05:31 pm EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now? - Insider Monkey

Mar 10, 2025
pulisher
Mar 10, 2025

Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie - Zacks Investment Research

Mar 10, 2025
pulisher
Mar 10, 2025

AbbVie Stock Hits All-Time High, Soars to $215.84 - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Is AbbVie Stock Expensive At $215? - Forbes

Mar 10, 2025
pulisher
Mar 10, 2025

Redburn Atlantic Adjusts Price Target on AbbVie to $234 From $216 -March 10, 2025 at 08:13 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy? - Yahoo Finance

Mar 10, 2025
pulisher
Mar 08, 2025

Pfizer, Walmart, Super Micro, Salesforce, AbbVie: Insider Moves Unveiled! - TipRanks

Mar 08, 2025
pulisher
Mar 07, 2025

AbbVie Inc. (ABBV): Among The Stocks With At Least $10 Million In Insider Sales Recently - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

AbbVie Options Trading: A Deep Dive into Market Sentiment - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Nanotechnology Drug Delivery Market to Witness Remarkable Growth with AbbVie Inc., Geistlich Pharma AG - openPR

Mar 07, 2025
pulisher
Mar 07, 2025

Graves Disease Overactive Thyroid Market Deep Research - openPR

Mar 07, 2025
pulisher
Mar 07, 2025

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Rx Rundown: AbbVie, Jazz Pharmaceuticals, Sofinnova Partners and more - MM+M Online

Mar 07, 2025
pulisher
Mar 07, 2025

This Insider Has Just Sold Shares In AbbVie - Simply Wall St

Mar 07, 2025
pulisher
Mar 07, 2025

Wells Fargo & Company Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock - Defense World

Mar 07, 2025

애브비 (ABBV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general NVO
$80.98
price up icon 1.04%
drug_manufacturers_general JNJ
$164.25
price up icon 0.87%
drug_manufacturers_general MRK
$94.72
price down icon 0.07%
drug_manufacturers_general NVS
$112.22
price up icon 0.00%
$318.65
price up icon 0.47%
자본화:     |  볼륨(24시간):